Literature DB >> 6799362

Biochemical and therapeutical studies in a case of atrophia gyrata.

W Behrens-Baumann, U König, K Schröder, I Hansmann, U Langenbeck.   

Abstract

A thirty-six years old man from an inbred family with the typical clinical picture of Atrophia gyrata chorioideae et retinae was found to have hyperornithinemia and a partial deficiency of ornithin-ketoacid-transaminase activity. The residual activity was stimulated in vitro by high concentrations of pyridoxal phosphate. We have initiated a therapeutic study with vitamin B6 per os accordingly. Comparitively low doses may be sufficient for long term treatment. The necessity to start therapy early in life is emphazised. Possible mechanisms of the pathogenesis of Atrophia gyrata are discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6799362     DOI: 10.1007/BF02134094

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  23 in total

1.  Gyrate atrophy of the choroid and retina: clinical, ophthalmologic, and biochemical considerations.

Authors:  C McCulloch; E B Marliss
Journal:  Trans Am Ophthalmol Soc       Date:  1975

Review 2.  Vitamin-responsive inherited metabolic disorders.

Authors:  L E Rosenberg
Journal:  Adv Hum Genet       Date:  1976

3.  Genetic aspects in gyrate atrophy of the choroid and retina with hyperornithinaemia.

Authors:  K Takki; O Simell
Journal:  Br J Ophthalmol       Date:  1974-11       Impact factor: 4.638

4.  Effects of non-metabolizable analogs on the distribution of amino acids in the rat.

Authors:  H N Christensen; A M Cullen
Journal:  Biochim Biophys Acta       Date:  1968-03-01

5.  [Ornithinemia, additional disorder of amino acid metabolism with brain damage].

Authors:  H Bickel; D Feist; H Müller; G Quadbeck
Journal:  Dtsch Med Wochenschr       Date:  1968-11-22       Impact factor: 0.628

6.  Hyperornithinaemia and gyrate atrophy of the retina: improvement of vision during treatment with a low-arginine diet.

Authors:  R R McInnes; S A Arshinoff; L Bell; E B Marliss; J C McCulloch
Journal:  Lancet       Date:  1981-03-07       Impact factor: 79.321

7.  Hyperornithinaemia associated with gyrate atrophy of the choroid and retina: in vivo and in vitro response to vitamin B6.

Authors:  K Tada; T Saito; K Omura; S Hayasaka; K Mizuno
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

8.  Gyrate atrophy of the choroid and retina with hyperornithinemia: characterization of mutant liver L-ornithine:2-oxoacid aminotransferase kinetics.

Authors:  I Sipilä; O Simell; J J O'Donnell
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

9.  Gyrate atrophy of the choroid and retina: deficiency of ornithine aminotransferase in transformed lymphocytes.

Authors:  D Valle; M I Kaiser-Kupfer; L A Del Valle
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

10.  Gyrate atrophy of the retina: inborn error of L-ornithin:2-oxoacid aminotransferase.

Authors:  J J O'Donnell; R P Sandman; S R Martin
Journal:  Science       Date:  1978-04-14       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.